Jonathan Charles Gee

Jonathan Charles Gee

Director/Board Member at Xention Pharma Ltd.

71 year
Health Technology
Finance
Consumer Services

Profile

Currently, Jonathan Charles Gee occupies the position of Investment Director and Chairman at SPARK Impact Ltd.
He is also on the board of 5 other companies.
In the past Dr. Gee occupied the position of Chief Executive Officer for IP2IPO Innovations Ltd., International Product Group Manager at Unipath Ltd., Principal at Quester GmbH and Investment Director at SPARK Venture Management Ltd.
Dr. Gee received a doctorate from the University of Oxford and an undergraduate degree from the University of Bristol.

Jonathan Charles Gee active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member 2012-10-31
Private Equity Investor -
All active positions of Jonathan Charles Gee

Former positions of Jonathan Charles Gee

CompaniesPositionEnd
Director/Board Member 2017-03-30
OXFORD IMMUNOTEC GLOBAL PLC Director/Board Member 2013-11-20
Director/Board Member 2012-06-14
Director/Board Member 2009-06-02
Director/Board Member -
See the detail of Jonathan Charles Gee's experience

Training of Jonathan Charles Gee

University of Oxford Doctorate Degree
University of Bristol Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonathan Charles Gee's experience

Connections

20

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies15

Health Technology

Finance

Health Technology

Distribution Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Finance

Quester Venture GP Ltd.

Finance

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Jonathan Charles Gee
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW